Skip to main content
. 2020 Oct 12;4(6):1037–1046. doi: 10.1002/jgh3.12426

Table 1.

Characteristics of the included studies

Author Year Type of study Location Country Event Sample Number by gender Age distribution Method of diagnosis Prevalence (%)
Ahmad 1997 CS Dhaka Bangladesh 166 181

M‐181

F‐0

20–44 years Hp serology 166/181 (91.7%)
Ahmad 2008 CS Islamabad Pakistan 289 400

M‐208

F‐192

3–16 years Urea breath test 289/400 (72.3%)
Augustine 2019 CS Kerala India 29 99

M‐NA

F‐NA

18–60 Years Hp serology 29/99 (29.3%)
Dore 1997 CS Karnataka India 41 50

M‐29

F‐21

6–18 years Urea breath test 41/50 (82%)
Fernando 2003 CS Western province Sri Lanka 37 359

M‐180

F‐179

1–94 years Hp serology 37/359 (10.30%)
Jafri 2009 CS Karachi Pakistan 926 1976

M‐1008

F‐968

1–15 years Hp serology 926/1976 (46.9%)
Jafri 2013 CS Karachi Pakistan 255 540

M‐256

F‐284

1–15 years Hp serology 255/540 (47.2%)
Mahskar 2010 CC Pune India 57 125

M‐62

F‐63

18–83 years Stool antigen test 57/125 (45.6%)
Mehmood 2014 CC Islamabad Pakistan 63 118

M‐63

F‐55

<25–>50 years Hp serology 63/118 (53.4%)
Prasad 1994 CC Vellore India 25 30

M‐NA

F‐NA

21–51 years Histology 25/30 (83.3%)
Priyadarshani 2018 CS Puducherry India 29 99

M‐59

F‐40

18–60 years Hp serology 29/99 (29.3%)
Rasheed 2011 CS Barakho, Islamabad Pakistan 384 516

M‐268

F‐248

2–>19 years Urea breath test 384/516 (74.4%)
Rifat‐uz‐Zaman 2006 CS Bahawalpur Pakistan 1756 3846

M‐2344

F‐1502

5–65 years Hp serology, urea breath test 1756/3846 (45.7%)
Romshoo 1997 CC Kashmir India 10 30

M‐25

F‐5

18–65 years Urease test, histology 10/30 (33.3%)
Sarker 1997 CS Nandipur, Dhaka Bangladesh 406 469

M‐NA

F‐NA

1–99 months Urea breath test 406/469 (86.6%)
Sarker 2004 CS Nandipur, Dhaka Bangladesh 145 182

M‐90

F‐92

1–5 years Urea breath test 145/182 (79.7%)
Singh 2002 CS Chandigarh India 38 67

M‐NA

F‐NA

15–75 years Hp serology, rapid urease test, histology 38/67 (56.7%)
Tewari 2012 CC Northern sector India 76 200

M‐NA

F‐NA

30–>85 years Hp serology 76/200 (38%)
Wangda 2017 CS Thimphu Bhutan 216 327

M‐145

F‐182

4–19 years Hp serology 216/327 (66.1%)

Data are expressed in proportion (%) if possible.

CC, Case–control; CS, cross‐sectional; F, female; M, male, NA, not available.